IRF3 as a transcription factor has been reported as a regulator in type I interferon genes playing a vital role in mammalian response to pathogens and considered to be implicated in various biological pathological conditions, including cancer (Wang et al., 2017; Andrilenas et al., 2018). Here, IRF3 is linked to cancer.